Try our Advanced Search for more refined results
Health - February, 2010
203 articles
- Software Co. Edifecs Sues Partner Over Trade Secrets
- Care Centers To Pay $14M In Omnicare Kickback Flap
- Watson Targets Teva's Patent For LoSeasonique
- Judge Won't Nix $22.5M Award In Pfizer Polio Suit
- Congress Urged To Fix Medical Radiation Standards
- J&J Unit Recalls 14,000 Blood Glucose Test Strips
- New MediCor Ch. 11 Plan Factors In Settlements
- Micron Loses Bid To Nix Claims In Drug Contract Spat
- Calif. AG Subpoenas Insurers Over Rate Hikes
- MIT Seeks To Exit Max Planck RNA Patent Suit
- Blue Cross Wins Deductible Class Action In 11th Circ.
- The Financial Case For Law Firm Branding
- KV To Pay $28M Over Ethex Drug Safety Charges
- Novartis Wins Out In Patent Suit Over Hemophilia Drug
- Cordis Wins $4.7M In Fees In MarcTec Stent Patent Suit
- DOJ Charges Guidant In Faulty Defibrillator Case
- Zimmer Loses Appeal To Keep Ex-VP From Rival
- Fed. Circ. Remands Denial Of Antibody Patent
- Active Implants Says Equity Firm Holding It Hostage
- SEC Fraud Claims Against Medical Capital Execs Nixed
- CVS Faces Suit Over Botched IPod Accessories Deal
- Chiropractors Ask To Toss Expert In Claim Fraud Suit
- Pfizer's Bid To Toss Protonix Medicaid Suits Denied
- House Votes To Revoke Insurer Antitrust Exemption
- Another Failed Attempt At Ill. Tort Reform
- SEC Fraud Case Against MedQuist Ex-CFO Trimmed
- Carestream Faces Suit Over Animal Imaging Patents
- GSK Blasts Senate Report On Avandia Risks
- Under Pressure, WellPoint Execs Stand By Rate Hikes
- Warner-Lambert Retirees Hit Pfizer Over Health Plan
- Synthes Bone Plate Patent Suit Stayed For Re-Exam
- Pfizer Seeks Sanctions In Wyeth Deal Antitrust Suit
- Mexico Fines Lilly, Others $12M For Price Collusion
- US Widens Probe Into Eli Lilly's FCPA Compliance
- Mont., Lilly Reach $9.5M Deal In Zyprexa MDL
- Novartis, Bayer Settle IP Spat Over Hemophilia Drugs
- KV Pharma Shareholder Suit Over Recalls Nixed
- Neurontin Suicide Case Survives Pfizer's Bid To Toss
- AndroGel Reverse Payment Suits Thrown Out
- Pfizer Must Pay $9.5M In Another Prempro Verdict
- Obama Takes Aim At Insurance Antitrust Exemption
- Allegra Suits Dropped After Sandoz Amends ANDAs
- Actavis Failure-To-Warn Suit Not Preempted: Judge
- 7th Circ. Rules Paxil Suicide Case Not Preempted
- AntiCancer Defends Validity Of Cancer Imaging Patents
- FDA Calls GSK's Avandia Safe Amid Public Concerns
- Triton Nabs Swedish Health Care Co. Ambea For $1.2B
- Rule 56 Compliance And The PTA Shield Of Rule 704
- OFT Accuses Reckitt Of Limiting Generic Access
- 3M Slaps Safe Life With Patent Suit Over Respirators
- Hedge Fund Hits Back At Biovail's 'False' Fraud Suits
- Digitek Defendants Seek to Block Class Cert.
- Sandoz Unit To Pay $3.5M In False Claims Act Deal
- Amicas Rejects $248M Rival Offer From Merge
- Tyco, Applied Medical Patent Battle To Move Ahead
- High Court Seeks SG Input On Procrit Whisteblower Suit
- McKesson, Angeles Ink $4.5M Deal To End Enviro Feud
- Senators Slam GSK, FDA On Avandia Safety
- Plaintiffs Fight Privilege Claim In Neurontin Case
- New Fees, Oversight In White House Health Care Bill
- Biovail Hammers Watson Over Aplenzin ANDA
- CORRECTED: Part Of Crestor Case Moves To Fla.
- FTC Has Shot At Victory In Pay-For-Delay Suits: Attys
- Hologic, J&J Unit Strike $12.5M Deal In Biopsy IP War
- Liberty Mutual, Aetna Put $20M E&O Fight On Hold
- Columbia's Patent Extension Spat To Return To USPTO
- Fraud Suit Against Walgreens Dismissed Again
- Waxman Calls Out WellPoint On Rate Hike Explanation
- Bayer Sues Lupin Over Generic Cipro
- Consumer Claims Pared In Redline Advertising Action
- 2nd Class Cert. Bid In Nurse Antitrust Suit Denied
- Asthma Drugs Get New Rules After FDA Finds Death Link
- Patton Boggs Lands Top Bristol-Myers Squibb Exec
- Teva Appeals Win For Pfizer In Detrol Patent Suit
- Novartis' Maalox Labels Linked With Serious Errors
- Patent Dispute Freezes Cold Sore Treatment Case
- Increasing Quality With Six Sigma
- GSK Recalls Zinc Denture Cream Products Amid MDL
- J&J Can't Revive Claims Against Abbott, Boston Sci
- Lupin Aims To Invalidate Ortho Birth Control Patent
- HHS Scolds Health Insurers For Requested Rate Hikes
- ReNu Lens Solution MDL Slashed By 100s Of Suits
- J&J Appeals Invalidity Ruling For Stent Patents
- Ill. Medical Imaging Center Antitrust Suit Tossed
- Grassley Demands Details On FDA 510(k) Update
- Roche Hit With $25M Accutane Verdict
- Plaintiff Class Wants Bristol-Myers AWP Deal Enforced
- USPTO Faces Another Suit To Extend Drug Patent
- 3rd Circ. Says Rite Aid Union Dispute Not Arbitrable
- Smith & Nephew Wins $4.7M In Arthrex Patent Spat
- Clinical Investigators Beware: Greater FDA Review
- ERISA, RICO Claims Out In Pittsburgh Hospital Pay Suit
- Walgreen To Snap Up Duane Reade For $1.1B
- Senate Dems Revive Push For Public Option
- Horny Goat Weed Deflates Pfizer's Viagra Patent
- Pfizer Experts Escape Judge's Boot In Neurontin Case
- Abbott Sues Sun Pharma Again Over Generic Niaspan
- J&J Unit Escapes Artificial Disc Negligence Claims
- Watson Settles Mass. Medicaid Fraud Suit For $2.4M
- Lilly Settles Ark.'s Zyprexa Marketing Suit For $18.5M
- Bayer Asks To Stop Nazi References In Trasylol MDL
- State Farm Payouts Violate Fla. No-Fault Law: Court
- Predicting SCOTUS In Merck V. Reynolds
- Teva, Novartis Settle Suit Over Generic Famvir
- Monsanto, Others Sued Over DNA Patent
- Prosthetic Liner Antitrust Claims Have Legs: Judge
- Indian Court Won't Block Generic Nexavar
- Pegasus, Allscripts Software IP Spat Headed To Jury
- Fund's Trasylol Marketing Suit Against Bayer Nixed
- WellPoint Defends Calif. Health Insurance Rate Hikes
- Lender Fights TLC Vision's Charlesbank Deal
- Judge Tosses Antitrust Claim In Ciba Vision IP Suit
- Pharmacies Stung In Medicaid Rates Suit V. Minn.
- Ariad: Sea Change Or Tempest In A Teapot?
- Couple Fined $4M In Biotech Insider Trading Scheme
- Perrigo ANDA Doesn't Infringe Mucinex Patent: Judge
- Judge Paves Way For McKesson To Appeal IP Loss
- Pretrial Clashes Intensify In Neurontin Off-Label MDL
- 9th Circ. Remands Neuralstem Stem Cell IP Suit
- Judge Nixes CVS 'Tactical Manipulation' In OT Suit
- Judge Tosses 'Borrowed' Suit Over Bayer Vitamins
- Abbott Divestment Wins EU OK For $6.6B Solvay Deal
- Digitek Plaintiffs Win Bid For Actavis Audit Docs
- United Insurers Dodge $400M In Settlement Claims
- Jury To Hear Max Planck RNA Interference Patent Suit
- Kasowitz Benson Hits Up Duane Reade For $7M Fee
- Curbing Antitrust Liability For New Products
- Dentsply Wants $44M Contract Suit Verdict Overturned
- Citigroup, KV Wrap Up ARS MDL Case
- Hogan & Hartson Wants To See Sealed Medtech Deal
- Sony Acquires Stem Cell Research Co. ICyt
- $12M Vioxx Deal Requires Merck To Add Safety Checks
- Acacia Recalls 217K IV Devices Over Faulty Component
- House Panel To Probe Anthem Blue Cross Rate Hike
- Pfizer, Sandoz Patent Spat Over Caduet Heads To Del.
- CCS Medical Disclosure Statement Approved
- Alza, Sandoz Pain Patch Case Stays In Federal Court
- Injunctions In District Courts And The ITC
- Drug Cos. Raise NY Law Query After AWP Loss
- Plaintiffs Ask Court To Revisit Neurontin Ruling
- Obamas Launch Fight Against Childhood Obesity
- UK Court Affirms Invalidity Of Gene Patent In Lilly Suit
- Howrey To Remain As BSC Counsel In Stent IP Suit
- Dykema's Rates Help Land Ex-Greenberg Litigator
- FDA Seeks To Reduce Radiation In Medical Scans
- Insurers Can't Dodge Cancer Patient Payout: 4th Circ.
- Texas A&M Blocked From Using Dog DNA Test Patents
- Coloplast Sues Generics Co. Over Incontinence Patents
- Officials Sound Alarm On Anthem Blue Cross Rate Hike
- Fat Removal Cos. Strike Licensing Deal In Patent Suit
- Class Cert. Denied In Health Temp Agency FLSA Suit
- Case Study: Donovan V. Philip Morris
- Becton Pulls Potentially Lethal IV Catheters
- Ortho Evra Plaintiffs Challenge Limited MD Contact
- Idera Sues USPTO To Extend Cancer Treatment Patents
- Judge Narrows Arguments In Arthrex Patent Trial
- DLA Piper Picks Up King & Spalding Litigator
- Granting A New Trial In Texas?
- Off-Label Marketing Ripe For Enforcement In 2010
- Fed. Circ. Nixes Pfizer Bid To Keep Lipitor IP Suit In Del.
- Reps To Pose Insurance Antitrust Exemption Repeal
- Physicians Group, FTC Settle Price-Fixing Suit
- Last Class Claims Tossed In ReNu Infection MDL
- Teva To Pay $315M To Settle Price Inflation Suits
- Reinsurer Gen Re Life Hits Insurer With False Ad Suit
- TLC Vision Eyes New Plan With Private Equity Backing
- SD Legislature Says No To Federal Health Care Bills
- Freedom Drops Market-Cornering Claims V. Novation
- Cardiac Science Recalls 12,200 Faulty Defibrillators
- Medtronic Securities Action Survives Dismissal Bid
- Bristol-Myers Worker Charged With Trade Secrets Theft
- Lilly To Pay Miss. $18.5M Over Zyprexa Marketing
- Inverness To Pay $110M For Kroll Drug Testing Unit
- McCain Proposal Would Increase Supplement Oversight
- Spheris Files Ch. 11 To Sell Off Assets For $75M
- GSK Sales Reps Appeal Dismissal Of OT Action
- Expert Testimony Back In Play In Accutane Death Suit
- A Response To 'NuvaRing Meets Iqbal'
- Pfizer Sues Mylan To Block Generic Caduet
- AtriCure Settles Medicare Fraud Claims For $3.8M
- FDA Says Eli Lilly Overstates Benefits Of Adcirca
- Agencies Roll Out Rules On Mental Health Coverage
- 2nd Circ. Shoots Down Zyprexa MDL Atty's Fee Appeal
- Jones Day Makes 3 More Lateral Hires In Calif.
- 3rd Circ. Tosses False Claims Suit Against Organon
- A Brief Overview Of MMSEA
- Medicis Sues Lupin To Halt Generic Acne Drug
- Nipro To Snap Up Home Diagnostics For $215M
- EU OKs $5B Deal Joining IMS Health, Investment Funds
- Lancet Retracts Study Linking MMR Vaccine To Autism
- 3rd Circ. Shoots Down J&J Sales Reps' OT Action
- Myriad, ACLU Square Off At Gene Patent Hearings
- Hologic Seeks 2nd Look At Ethicon Willfulness Claim
- Celgene, Novartis Settle With Teva In Focalin IP Suits
- Merge Wants Ex-Execs To Pay Back Defense Fees
- Applikon Fights Customs Over Bioreactor Duties
- Boston Scientific To Pay J&J $1.7B In Stent Settlement
- La. AG Wants Vioxx Suit Returned To State Court
- Robot Not Cause Of Patient's Impotence: 3rd Circ.
- Baylor Loses Bid To Force Insurer To Arbitrate Contract
- USPTO, FDA Sued Over Angiomax Patent Extension
- Affirming The Right To Rescind In Calif.
- Cephalon To Buy Swiss Drugmaker Mepha For $590M